HEALTH OF WOMAN. 2019.7(143): 9–13; doi 10.15574/HW.2019.143.9

V.O. Benyuk, M.S. Puchko, A.A. Momot, L.E. Dombrovskyi
Bogomolets National Medical University, Kiev

The article highlights the latest approaches to the use of CO2-laser in modern gynecological practice. After all, patients with urinary incontinence, urogenital disorders in the menopausal period, vaginal relaxation syndrome, vaginal wall prolapse and scarring of the vulva make the main contingent of aesthetic gynecology offices in Ukraine.

The main reasons that lead to the occurrence of these complications include changes in the genital organs during pregnancy and childbirth, the tension of the pelvic floor diaphragm muscles, connective tissue dysplasia, estrogen deficiency and, as a consequence, the loss of collagen and elastin in the tissues of the genital organs.

Today, there are a number of techniques that allow the correction of these complications – conservative, surgical, physiotherapy and psychological.

The newest method in the treatment of vagina and vulva atrophic is the application of CO2-laser, which is widely used outside of Ukraine. Under the influence of laser in tissues remodeling processes occur as a response to their damage, enhanced synthesis of collagen and elastic fibers. The positive effect of the latest technique is highlighted in the works of Italian researchers. However, in Ukraine, this method is not common, and the experience of its own use is not sufficient, which led to the prospect of further research.

Key words: aesthetic gynecology, urinary incontinence, vaginal mucosa atrophy, vaginal wall prolapse, vaginal deformation, CO2-laser.

REFERENCES

1. Apolihina IA, Gorbunova EA, Odinokova VA. 2014. Maloinvazivnyie innovatsionnyie lazernyie tehnologii v ginekologicheskoy praktike. Akusherstvo i ginekologiya 11:17–22.

2. Bezmenko AA, Shmidt AA, Koval AA, Karpischenko ZhM. 2014. Konservativnyie metodyi lecheniya nederzhaniya mochi pri napryazhenii u zhenschin. Vestnik Rossiyskoy Voenno-meditsinskoy akademii 45(1): 227–232.

3. Veropotvelian PN, Tsekhmystrenko YS, Veropotvelian NP, Huzhevskaia YV. 2014. Atrofyia slyzystoi vlahalyshcha u patsyentok v postmenopauze. Zbirnyk naukovykh prats Asotsiatsii akusheriv-hinekolohiv Ukrainy 1/2 (33/34): 69–76.

4. Haspar E, Edemo H, Brendi Kh. 2012. Fraktsiinyi CO2-lazer: minimalno invazyvnyi metod omolodzhennia pikhvy. Plastychna khirurhiia i kosmetologiia 1: 1–4.

5. Hvozdov MIu, Tupikina NV, Kasian HR, Pushkar DIu. 2016. Prolaps tazovykh orhaniv u klinichnii praktytsi likaria-uroloha. Metodychni rekomendatsii 2: 22–38.

6. De Leon Frenk D, Maikl S Bahhish. 2008. Lazery v hinekolohii. Zhinocha medytsyna. (ISSN: 1756-2228) DOI 10.3843 / GLOWM.10023

7. Korkan AI. 2009. Prolaps tazovyih organov. Diagnostika, hirurgicheskaya taktika. Monografiya. Almaty: 168.

8. Lihachev VK. 2013. Prakticheskaya ginekologiya s neotlozhnymi sostoyaniyami. M, GEOTAR-Media:128.

9. Marakshin YuK. 2013. Vaginalne omolodzhennya. Estetychna meditsina. Metamorfozi 3: 54–59.

10. Neymark AI. 2013. Nederzhanie mochi u zhenschin: rukovodstvo. M, GEOTAR-Media: 128.

11. Peryno A, Kalliharo A, Forlani F, Tyberio K, Kuchynella H, Svelato A, Saytta S, Kalania H. 2014. Vulvovahinalna atrofiia: novyi metod likuvannia za dopomohoiu termoabliatsiinoho fraktsiinoho lazera SO2. ELZEVIR 3: 1–6.

12. Rogovoskoy SI, Lipovoy EV. 2014. Sheyka matki, vlagalische, vulva. Fiziologiya, patologiya, kolposkopiya, esteticheskaya korrektsiya. Rukovodstvo dlya praktikuyuschih vrachey. Izd-vo zhurnala Status Praesens: 832.

13. Salvatore S, Madzhore LR, Orihoni M, Kandiani M, Sileo F, Kola A, Baini I, Ferero S, Tserbinati N. 2014. Mikroabliatsiinyi fraktsiinyi CO2-lazer pokrashchuie dyspareuniiu, poviazanu z vulvovahinalnoiu atrofiieiu: pilotne doslidzhennia. Zhurnal endometriozu ta rozladiv tazovoho boliu. 18 (4): 24–29.

14. Salvatore S, Madzhore ULR, Afanasiu S, Orihoni M, Kandiani M, Kalliharo A, Tserbinati N. 2015. Histolohichne doslidzhennia vplyvu fraktsiinoho mikroabliatsiinoho SO2-lazera na atrofichnu vahinalnu tkanynu: doslidzhennia ex vivo. Pivnichnoamerykanske suspilstvo z vyvchennia menopauzy 22 (8): 845–849.

15. Satton SD, Dzhons KD. 2002. Lazerna laparoskopiia dlia endometriozu ta endometrioidnykh kist. Surg Endosc. 16: 1513–1517.

16. Smetnik VP. 2012. Estrogenyi. M, Prakticheskaya Meditsina: 176.

17. Filipini M. 2014. Zastosuvannia MonaLisa Touch (Monaliza Tach) pry likuvanni khvorykh na rak. Instytut sotsialnoho zakhystu. San-Maryno 1–4.

18. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. 2005. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 52 (1): 46–52. https://doi.org/10.1016/j.maturitas.2005.06.014; PMid:16139449

19. Fistonic N, Fistonic I, Lukanovic A, Findri Gustek S, Sorta Bilajac Turina I, Franic D. 2015. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 18 (1): 37–42. https://doi.org/10.3109/13697137.2015.1071126; PMid:26366799

20. Frank SM, Ziegler C, Kokot-Kierepa M, Maamari R, Nappi RE. 2013. Vaginal Health: Insights, Views & Attitudes (VIVA) survey – Canadian cohort. Menopause Int. 19 (1) 20–27. https://doi.org/10.1258/mi.2012.012034; PMid:23201626

21. Griebling TL, Liao Z, Smith PG. 2012. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopal women. Menopause 19 (6) : 630–635. https://doi.org/10.1097/gme.0b013e31823b8983; PMid:22205148 PMCid:PMC3319450

22. Lotze EC, Grunert GM. 1989. The use of lasers in infertilitysurgery. Clin Obstet Gynecol. 79: 323.

23. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 20 (9): 888–902. 2013. https://doi.org/10.1097/GME.0b013e3182a122c2; PMid:23985562

24. Minassian VA, Stewart WF, Wood GC. 2008. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet. Gynecol. 111 (2): 324–331. https://doi.org/10.1097/01.AOG.0000267220.48987.17; PMid:18238969

25. Ogrinc UB, Senčar S, Lenasi H. 2015. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg. Med. 2015. 47 (9): 689–697. https://doi.org/10.1002/lsm.22416; PMid:26388213 PMCid:PMC5396289

26. Palacios S. 2009. Managing urogenital atrophy. Maturitas. 63 (4): 315–318. https://doi.org/10.1016/j.maturitas.2009.04.009; PMid:19493638

27. Pickar JH. 2013. Emerging therapies for postmenopausal vaginal atrophy. Maturitas. 75 (1): 3–6. https://doi.org/10.1016/j.maturitas.2013.01.020; PMid:23434231

28. Sinha A, Ewies AA. 2013. Non-hormonal topical treatment of vulvovaginal atrophy: an upto-date overview. Climacteric. 16 (3): 305–312. https://doi.org/10.3109/13697137.2012.756466; PMid:23215675

29. Sturdee DW, Panay N. 2010. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 13: 509–522. https://doi.org/10.3109/13697137.2010.522875; PMid:20883118

30. Walker GJ, Gunasekera P. 2011. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecology J. 22 (2) 127–135. https://doi.org/10.1007/s00192-010-1215-0; PMid:20617303

31. Zhu L, Lang J, Liu C, Han S, Huang J, Li X. 2009. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China. Menopause. 16 (4): 831–836. https://doi.org/10.1097/gme.0b013e3181967b5d; PMid:19240656